Barclays’s OrthoPediatrics KIDS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $51K | Sell |
3,211
-23,194
| -88% | -$405K | ﹤0.01% | 4316 |
|
|
2025
Q4 | $469K | Buy |
26,405
+2,561
| +11% | +$44.8K | ﹤0.01% | 3887 |
|
|
2025
Q3 | $442K | Sell |
23,844
-8,184
| -26% | -$169K | ﹤0.01% | 3887 |
|
|
2025
Q2 | $688K | Buy |
32,028
+11,971
| +60% | +$259K | ﹤0.01% | 3573 |
|
|
2025
Q1 | $494K | Sell |
20,057
-8,333
| -29% | -$206K | ﹤0.01% | 3538 |
|
|
2024
Q4 | $658K | Buy |
28,390
+3,092
| +12% | +$77.3K | ﹤0.01% | 3656 |
|
|
2024
Q3 | $686K | Buy |
25,298
+19,264
| +319% | +$584K | ﹤0.01% | 3582 |
|
|
2024
Q2 | $174K | Sell |
6,034
-10,029
| -62% | -$307K | ﹤0.01% | 3649 |
|
|
2024
Q1 | $468K | Sell |
16,063
-8,980
| -36% | -$251K | ﹤0.01% | 3634 |
|
|
2023
Q4 | $814K | Buy |
25,043
+15,759
| +170% | +$457K | ﹤0.01% | 3598 |
|
|
2023
Q3 | $297K | Buy |
9,284
+3,016
| +48% | +$116K | ﹤0.01% | 3086 |
|
|
2023
Q2 | $275K | Sell |
6,268
-1,407
| -18% | -$64.9K | ﹤0.01% | 3096 |
|
|
2023
Q1 | $340K | Buy |
7,675
+3,601
| +88% | +$159K | ﹤0.01% | 3516 |
|
|
2022
Q4 | $162K | Buy |
4,074
+3,441
| +544% | +$143K | ﹤0.01% | 3964 |
|
|
2022
Q3 | $29K | Sell |
633
-90
| -12% | -$4.41K | ﹤0.01% | 3950 |
|
|
2022
Q2 | $31K | Sell |
723
-1,587
| -69% | -$72.6K | ﹤0.01% | 4232 |
|
|
2022
Q1 | $124K | Sell |
2,310
-14,481
| -86% | -$740K | ﹤0.01% | 3692 |
|
|
2021
Q4 | $1.01M | Buy |
16,791
+11,138
| +197% | +$693K | ﹤0.01% | 2832 |
|
|
2021
Q3 | $370K | Buy |
5,653
+3,902
| +223% | +$253K | ﹤0.01% | 3334 |
|
|
2021
Q2 | $111K | Sell |
1,751
-9,210
| -84% | -$529K | ﹤0.01% | 3808 |
|
|
2021
Q1 | $534K | Buy |
10,961
+4,829
| +79% | +$232K | ﹤0.01% | 3138 |
|
|
2020
Q4 | $252K | Sell |
6,132
-2,154
| -26% | -$98.8K | ﹤0.01% | 3633 |
|
|
2020
Q3 | $381K | Sell |
8,286
-480
| -5% | -$22.3K | ﹤0.01% | 3432 |
|
|
2020
Q2 | $383K | Buy |
8,766
+3,233
| +58% | +$145K | ﹤0.01% | 3557 |
|
|
2020
Q1 | $219K | Sell |
5,533
-3,399
| -38% | -$152K | ﹤0.01% | 4231 |
|
|
2019
Q4 | $419K | Buy |
8,932
+4,531
| +103% | +$176K | ﹤0.01% | 4444 |
|
|
2019
Q3 | $155K | Sell |
4,401
-1,851
| -30% | -$64.1K | ﹤0.01% | 5149 |
|
|
2019
Q2 | $244K | Buy |
6,252
+2,742
| +78% | +$111K | ﹤0.01% | 4934 |
|
|
2019
Q1 | $156K | Buy |
3,510
+3,264
| +1,327% | +$124K | ﹤0.01% | 5011 |
|
|
2018
Q4 | $9K | Sell |
246
-2,391
| -91% | -$75.8K | ﹤0.01% | 6214 |
|
|
2018
Q3 | $96K | Buy |
2,637
+2,131
| +421% | +$65.3K | ﹤0.01% | 5578 |
|
|
2018
Q2 | $14K | Sell |
506
-621
| -55% | -$13.3K | ﹤0.01% | 6377 |
|
|
2018
Q1 | $17K | Buy |
1,127
+390
| +53% | +$6.91K | ﹤0.01% | 6491 |
|
|
2017
Q4 | $14K | Buy |
+737
| New | +$14.1K | ﹤0.01% | 6425 |
|
Other funds holding KIDS
B
GIM
VCM
SCM
Barclays's KIDS Position: Q1 2026 in Review
Barclays reduced its OrthoPediatrics (KIDS) stake by 88% in Q1 2026, selling an estimated $405K and leaving 3,211 shares worth $51K. The position accounts for ﹤0.01% of the portfolio, ranked #4316.
Barclays first reported a position in KIDS in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.01M in Q4 2021. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2026.
- Barclays held 3,211 shares of OrthoPediatrics worth $51K as of Q1 2026.
- Barclays sold 23,194 OrthoPediatrics shares in Q1 2026, an estimated $405K.
- OrthoPediatrics made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4316 holding.
- Barclays first reported a position in OrthoPediatrics in Q4 2017 and has held it in 34 quarters since.
- Barclays's OrthoPediatrics position peaked at $1.01M in Q4 2021.
- 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.